Free Trial

SAB Biotherapeutics (SABS) Short Interest Ratio & Short Volume

SAB Biotherapeutics logo
$3.13 +0.06 (+1.95%)
(As of 11/22/2024 ET)

SAB Biotherapeutics Short Interest Data

SAB Biotherapeutics (SABS) has a short interest of 58,800 shares, representing 0.79% of the float (the number of shares available for trading by the public). This marks a -26.32% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 83,235 shares to cover all short positions.

Current Short Interest
58,800 shares
Previous Short Interest
79,800 shares
Change Vs. Previous Month
-26.32%
Dollar Volume Sold Short
$191,688.00
Short Interest Ratio
0.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
9,230,000 shares
Float Size
7,490,000 shares
Short Percent of Float
0.79%
Today's Trading Volume
28,433 shares
Average Trading Volume
83,235 shares
Today's Volume Vs. Average
34%
Short Selling SAB Biotherapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for SAB Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SABS Short Interest Over Time

SABS Days to Cover Over Time

SABS Percentage of Float Shorted Over Time

SAB Biotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202458,800 shares $191,688.00 -26.3%0.8%0.9 $3.26
10/15/202479,800 shares $193,116.00 +92.3%1.1%1.6 $2.42
9/30/202441,500 shares $112,050.00 +37.4%0.6%2.3 $2.70
9/15/202430,200 shares $84,258.00 -12.7%0.4%1.9 $2.79
8/31/202434,600 shares $101,724.00 +32.1%0.5%3.7 $2.94
8/15/202426,200 shares $58,950.00 -8.1%0.4%2.6 $2.25
7/31/202428,500 shares $79,093.20 +8.0%0.4%1.7 $2.78
7/15/202426,400 shares $76,560.00 -17.0%0.4%1.6 $2.90
6/30/202431,800 shares $98,580.00 -7.0%0.4%2 $3.10
6/15/202434,200 shares $107,730.00 +0.9%0.5%2.1 $3.15
5/31/202433,900 shares $89,496.00 +50.7%0.5%1.9 $2.64
5/15/202422,500 shares $88,425.00 No Change0.3%1.2 $3.93
4/30/202422,500 shares $96,525.00 -12.1%0.3%1.7 $4.29
4/15/202425,600 shares $111,616.00 -11.4%0.3%1.8 $4.36
3/31/202428,900 shares $131,206.00 +38.3%0.4%1.7 $4.54
3/15/202420,900 shares $115,368.00 -15.0%0.3%1.1 $5.52
2/29/202424,600 shares $109,716.00 -37.1%0.3%1.5 $4.46
2/15/202439,100 shares $217,005.00 +17.8%0.5%2.9 $5.55
1/31/202433,200 shares $199,200.00 +90.8%0.4%2.8 $6.00
1/15/202417,400 shares $104,052.00 -2.8%0.2%1.5 $5.98
12/31/202317,900 shares $12,306.25 -91.4%N/A2.1 $0.69
12/15/2023207,600 shares $153,291.84 -11.2%0.3%3 $0.74
11/30/2023233,700 shares $227,156.40 +1.7%0.7%3.8 $0.97
11/15/2023229,800 shares $209,118.00 -12.1%0.6%4.4 $0.91
10/31/2023261,400 shares $261,373.86 -2.2%0.7%5.2 $1.00
10/15/2023267,200 shares $187,574.40 -2.8%0.7%6.4 $0.70
9/30/2023274,900 shares $173,187.00 -10.3%0.7%7.4 $0.63
9/15/2023306,500 shares $199,225.00 -17.5%0.8%8.5 $0.65
8/31/2023371,600 shares $267,552.00 +8.8%1.0%7 $0.72
8/15/2023341,500 shares $269,785.00 -12.3%0.9%5.9 $0.79
7/31/2023389,300 shares $315,333.00 -12.4%1.1%4.7 $0.81
7/15/2023444,400 shares $385,472.56 -4.1%1.3%1.6 $0.87
6/30/2023463,200 shares $384,456.00 +27.2%1.3%0.3 $0.83
6/15/2023364,300 shares $329,691.50 -14.9%1.0%0.3 $0.91
5/31/2023428,100 shares $381,009.00 -35.7%1.2%0.3 $0.89
5/15/2023665,400 shares $585,552.00 +28.3%1.9%0.5 $0.88
4/30/2023518,600 shares $465,858.38 +287.6%1.5%0.4 $0.90
4/15/2023133,800 shares $97,071.90 -3.2%0.4%0.1 $0.73
3/31/2023138,200 shares $60,808.00 -30.1%0.4%3.4 $0.44
3/15/2023197,800 shares $100,878.00 +17.5%0.6%4.3 $0.51
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

2/28/2023168,300 shares $109,395.00 +14.1%0.5%3.2 $0.65
2/15/2023147,500 shares $97,792.50 -2.8%0.5%2.7 $0.66
1/31/2023151,700 shares $103,064.98 +3.1%0.5%2.3 $0.68
1/15/2023147,100 shares $109,427.69 -14.4%0.5%2.1 $0.74
12/30/2022171,800 shares $101,344.82 -14.4%0.6%2.5 $0.59
12/15/2022200,700 shares $184,684.14 -6.1%0.7%2.8 $0.92
11/30/2022213,700 shares $230,796.00 -11.1%0.8%2.8 $1.08
11/15/2022240,300 shares $254,718.00 +8.2%0.9%3.1 $1.06
10/31/2022222,200 shares $199,980.00 -15.3%0.8%3.1 $0.90
10/15/2022262,400 shares $208,634.24 +7.7%0.9%3.8 $0.80
9/30/2022243,600 shares $170,763.60 +22.8%0.9%3.6 $0.70
9/15/2022198,300 shares $164,589.00 -22.1%0.7%3.6 $0.83
8/31/2022254,600 shares $178,245.46 +6.3%1.0%4.5 $0.70
8/15/2022239,500 shares $287,400.00 -6.4%0.9%4.9 $1.20
7/31/2022255,900 shares $276,372.00 -3.4%1.0%5.3 $1.08
7/15/2022265,000 shares $315,350.00 -8.8%1.0%5.7 $1.19
6/30/2022290,700 shares $421,515.00 +17.1%1.1%4.5 $1.45
6/15/2022248,300 shares $330,239.00 -19.8%1.0%1.2 $1.33
5/31/2022309,600 shares $606,816.00 +19.8%1.2%1.5 $1.96
5/15/2022258,500 shares $514,415.00 -2.5%1.1%1.1 $1.99
4/30/2022265,100 shares $662,750.00 +3.7%1.1%1.2 $2.50
4/15/2022255,700 shares $736,416.00 -12.8%1.0%1.1 $2.88
3/31/2022293,200 shares $1.10 million -6.7%1.2%1.3 $3.76
3/15/2022314,400 shares $572,208.00 -30.0%1.3%2.9 $1.82
2/28/2022449,000 shares $2.23 million -5.9%1.8%2.7 $4.96
2/15/2022477,000 shares $2.57 million -0.1%1.9%2.3 $5.39
1/31/2022477,400 shares $2.77 million +19.7%1.9%1.9 $5.81
1/15/2022398,700 shares $2.69 million -26.9%1.6%1 $6.75
12/31/2021545,400 shares $4.26 million No Change2.2%0.8 $7.81

SABS Short Interest - Frequently Asked Questions

What is SAB Biotherapeutics' current short interest?

Short interest is the volume of SAB Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 58,800 shares of SABS short. 0.79% of SAB Biotherapeutics' shares are currently sold short. Learn More on SAB Biotherapeutics' current short interest.

What is a good short interest ratio for SAB Biotherapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SABS shares currently have a short interest ratio of 1.0. Learn More on SAB Biotherapeutics's short interest ratio.

What is a good short interest percentage for SAB Biotherapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.79% of SAB Biotherapeutics' floating shares are currently sold short.

Is SAB Biotherapeutics' short interest increasing or decreasing?

SAB Biotherapeutics saw a decrease in short interest in October. As of October 31st, there was short interest totaling 58,800 shares, a decrease of 26.3% from the previous total of 79,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is SAB Biotherapeutics' float size?

SAB Biotherapeutics currently has issued a total of 9,230,000 shares. Some of SAB Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SAB Biotherapeutics currently has a public float of 7,490,000 shares.

How does SAB Biotherapeutics' short interest compare to its competitors?

0.79% of SAB Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to SAB Biotherapeutics: Regulus Therapeutics Inc. (3.19%), Agenus Inc. (13.16%), Fortress Biotech, Inc. (11.97%), Curis, Inc. (1.84%), Bolt Biotherapeutics, Inc. (0.26%), Molecular Templates, Inc. (4.97%), Amgen Inc. (1.64%), Vertex Pharmaceuticals Incorporated (1.75%), Gilead Sciences, Inc. (1.43%), Regeneron Pharmaceuticals, Inc. (1.68%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short SAB Biotherapeutics stock?

Short selling SABS is an investing strategy that aims to generate trading profit from SAB Biotherapeutics as its price is falling. SABS shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against SAB Biotherapeutics?

A short squeeze for SAB Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SABS, which in turn drives the price of the stock up even further.

How often is SAB Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SABS, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:SABS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners